The protective effects of S14G-humanin (HNG) against streptozotocin (STZ)-induced cardiac dysfunction

References

• Athithan L, Gulsin G, McCann G, et al. Diabetic cardiomyopathy: pathophysiology, theories and evidence to date. World J Diabetes. 2019;10(10):490–510.
   PubMed Web of Science ®Google Scholar
• Boudina S, Abel E. Diabetic cardiomyopathy causes and effects. Rev Endocr Metab Disord. 2010;11(1):31–39.
   PubMed Web of Science ®Google Scholar
• Jia G, Hill M, Sowers J. Diabetic cardiomyopathy-an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624–638.
   PubMed Web of Science ®Google Scholar
• Baynes J, Thorpe S. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999 Jan;48(1):1–9.
   PubMed Web of Science ®Google Scholar
• Uemura S, Matsushita H, Li W, et al. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res. 2001 Jun 22;88(12):1291–1298.
   PubMed Web of Science ®Google Scholar
• Liu Q, Wang S, Cai L. Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage. J Diabetes Investig. 2014;5(6):623–634.
   PubMed Web of Science ®Google Scholar
• Cai L. and Kang Y J. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol. 2001;1(3):181–193.
   PubMedGoogle Scholar
• Smail M, Howarth C, Singh J, et al. Inflammation and Diabetic Cardiomyopathy. Open access peer-rev chapter. 2019. doi:10.5772/intechopen.88149
   Google Scholar
• Nunes S, Soares PF, Reis F. The role of inflammation in diabetic cardiomyopathy. Int J Interferon Cytokine Mediat Res. 2012;2012(4):59–73.
   Google Scholar
• Berenji K, Drazner MH, Rothermel BA, et al. Does load-induced ventricular hypertrophy progress to systolic heart failure? American Journal of Physiology-Heart and Circulatory Physiology. 2005;289(1):H8–H16.
   PubMed Web of Science ®Google Scholar
• Chung E, Leinwand LA. Pregnancy as a cardiac stress model. Cardiovascular Research. 2014;101(4):561–570.
   PubMed Web of Science ®Google Scholar
• Ellison GM, Waring CD, Vicinanza C, Ellison GM, Waring CD, Vicinanza C, and Torella D. Physiological cardiac remodelling in response to endurance exercise training: cellular and molecularmechanisms. Heart. 2012;98(1):5–10.
   PubMed Web of Science ®Google Scholar
• Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol. 2006;7(8):589–600.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Dannenberg AL, Levy D. Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol. 1987;60(17):85I–931.
   PubMed Web of Science ®Google Scholar
• Wang S, Ding L, Ji H, et al. The role of p38 MAPK in the development of diabetic cardiomyopathy. Int J Mol Sci. 2016 Jun 30;17(7):1037.
   PubMed Web of Science ®Google Scholar
• Adhikary L, Chow F, Nikolic-Paterson DJ, et al. Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia. 2004;47(7):1210–1222.
   PubMed Web of Science ®Google Scholar
• Mackay K, Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem. 1999;274(10):6272–6279.
   PubMed Web of Science ®Google Scholar
• Ono R, Fukunaga A, Masaki T, et al. Suppressive effect of administration of recombinant human thioredoxin on cutaneous inflammation caused by UV. Bioengineered. 2013;4(4):254–257.
   PubMed Web of Science ®Google Scholar
• Li M, Georgakopoulos D, Lu G, et al. p38 MAP kinase mediates inflammatory cytokine induction in cardiomyocytes and extracellular matrix remodeling in heart. Circulation. 2005;111(19):2494–2502.
   PubMed Web of Science ®Google Scholar
• Lorenzo O, Picatoste B, Ares-Carrasco S, et al. Potential role of nuclear factor κb in diabetic cardiomyopathy. Mediators Inflamm. 2011;2011:1–9.
   Web of Science ®Google Scholar
• Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res. 2011;108(9):1122–1132.
   PubMed Web of Science ®Google Scholar
• Kumar S, Wei C, Thomas C, et al. Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system. Am J Physiol Heart Circ Physiol. 2014 1;307(7):H1036–45.
   PubMed Web of Science ®Google Scholar
• Kumar R, Yong QC, Thomas CM. Do multiple nuclear factor κB activation mechanisms explain its varied effects in the heart? Ochsner J. 2013;13:157–165.
   PubMedGoogle Scholar
• Lorenzo O, Picatoste B, Ares-Carrasco S, et al. Potential role of nuclear factor κB in diabetic cardiomyopathy. Mediators Inflamm. 2011;652097:2011.
   Google Scholar
• Lue Y, Swerdloff R, Wan J, et al. The Potent Humanin Analogue (HNG) protects germ cells and leucocytes while enhancing chemotherapy-induced suppression of cancer metastases in male mice. Endocrinology. 2015;156(12):4511–4521.
   PubMed Web of Science ®Google Scholar
• Li X, Zhao W, Yang H, et al. S14G-humaninrestored cellular homeostasis disturbed by amyloid-beta protein. Neural Regen Res. 2013;8:2573–2580.
   PubMed Web of Science ®Google Scholar
• Arafa EA, Hassan W, Murtaza G, et al. Ficus carica and sizigium cumini regulate glucose and lipid parameters in high-fat diet and streptozocin-induced rats. J Diabetes Res. 2020;2020:6745873.
   PubMed Web of Science ®Google Scholar
• Solares-Pascasio JI, Ceballos G, Calzada F, et al. Antihyperglycemic and lipid profile effects of salvia amarissima ortega on streptozocin-induced type 2 diabetic mice. Molecules. 2021;26(4):4.
   Web of Science ®Google Scholar
• Zhou Y. The protective effects of cryptochlorogenic acid on β-cells function in diabetes in vivo and vitro via inhibition of ferroptosis. Diabetes Metab Syndr Obes. 2020;13:1921–1931.
   PubMed Web of Science ®Google Scholar
• Li YX, Gao YB, Gong YB, et al. Treatment with Tang-luo-ning altered the microRNA expression profile in rats with diabetic peripheral neuropathy. Bioengineered. 2020;11(1):841–851.
   PubMed Web of Science ®Google Scholar
• Guo K, Wu J, Kong Y, et al. Label-free and noninvasive method for assessing the metabolic status in type 2 diabetic rats with myocardium diastolic dysfunction. Biomed Opt Express. 2020;12(1):480–493.
   PubMed Web of Science ®Google Scholar
• Nong A, Li QF, Huang ZJ, et al. MicroRNA miR-126 attenuates brain injury in septic rats via NF-κB signalling pathway. Bioengineered. 2021;12(1):2639–2648.
   PubMed Web of Science ®Google Scholar
• Danese E, Montagnana M. An historical approach to the diagnostic biomarkers of acute coronary syndrome. Ann Transl Med. 2016;4(10):194.
   PubMed Web of Science ®Google Scholar
• Mythili S, Malathi N. Diagnostic markers of acute myocardial infarction. Biomed Rep. 2015;3(6):743–748.
   PubMed Web of Science ®Google Scholar
• Navarro-González J, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. Journal of the American Society of Nephrology. 2008;19(3):433–442.
   PubMed Web of Science ®Google Scholar
• Nishio Y, Kashiwagi A, Taki H, et al. Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes. 1998;47(8):1318–1325.
   PubMed Web of Science ®Google Scholar
• Kaul N, Siveski-Iliskovic N, Hill M, et al. Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy. Mol Cell Biochem. 1996;160-161(1):283–288.
   PubMedGoogle Scholar
• Hansen S, Aasum E, Hafstad A. The role of NADPH oxidases in diabetic cardiomyopathy. Biochim Biophys Acta (BBA) - Mol Basis Dis. 1864;2018:1908–1913.
   Google Scholar
• Matsumoto H, Silverton S, Debolt K, et al. Superoxide dismutase and catalase activities in the growth cartilage: relationship between oxidoreductase activity and chondrocyte maturation. J Bone Miner Res. 1991;569–574. DOI:10.1002/jbmr.5650060607
   PubMed Web of Science ®Google Scholar
• Lobo V, Patil A, Phatak A, et al. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev. 2010 Jul-Dec;4(8):118–126.
   PubMedGoogle Scholar
• Ighodaro O, Akinloye O. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alexandria J Med. 2018;54(4):287–293.
   Web of Science ®Google Scholar
• Malek AM, Alper S, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA. 1999;282:2035–2042.
   PubMed Web of Science ®Google Scholar
• Dinh W, Füth R, Nickl W, et al. Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetol. 2009;8(1):58. Article number
   PubMedGoogle Scholar
• Cuenda A, Rousseaua S. p38 MAP-Kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta, Mol Cell Res. 1773(8): 1358–1375.
   Web of Science ®Google Scholar
• Lawrence T. The Nuclear Factor NF-κB Pathway in Inflammation. Cold SprRBiol. 2009 Dec 1;6:a001651.
   Google Scholar
• Feng QZ, Cheng LQ, Li YF. Progressive deterioration of left ventricular function in a patient with a normal coronary angiogram. World J Cardiol. 2012;4(4):130–134.
   PubMedGoogle Scholar